WEDGE CAPITAL MANAGEMENT L L P/NC
Position in BCRX — Biocryst Pharmaceuticals Inc
CIK 1015308
CHARLOTTE, NC
Position in BCRX
as of Jun 30, 2026
· filed Jul 10, 2026
Position Value
$3,808,010
New position
Shares Held
380,801
first reported quarter
Ownership
0.149%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#72
of 316 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 32%
Shared 0%
None 68%
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026WEDGE CAPITAL MANAGEMENT L L P/NC holds $47,806,751 across 8 Drug Manufacturers - Specialty & Generic names. BCRX ranks #2 (8.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VTRS |
Viatris Inc
|
1,856,208 | $29,476,583 | |
| 2 | BCRX |
Biocryst Pharmaceuticals Inc
This page
|
380,801 | $3,808,010 | |
| 3 | SUPN |
Supernus Pharmaceuticals, Inc.
|
68,885 | $3,203,841 | |
| 4 | PBH |
Prestige Consumer Healthcare Inc.
|
61,203 | $2,893,065 | |
| 5 | COLL |
Collegium Pharmaceutical, Inc
|
71,523 | $2,589,132 | |
| 6 | PCRX |
Pacira BioSciences, Inc.
|
94,554 | $2,398,834 | |
| 7 | IRWD |
Ironwood Pharmaceuticals Inc
|
435,650 | $1,834,086 | |
| 8 | ANIP |
Ani Pharmaceuticals Inc
|
19,367 | $1,603,200 |
All Filings in BCRX
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,808,010 | 380,801 | Shares | Sole | 2026-07-10 | |
| No filing history on record for this holder in this stock. | ||||||